Covid-19 roundup: Trump administration prepping exec order to reduce reliance on foreign manufacturing of 'essential medicines'
Back when President Trump was championing the potential of the malaria drug hydroxychloroquine, he convinced the Indian government to relax its export restrictions to supply the United States. Indeed, most generic therapies in the country are manufactured in India and China — and now, as the coronavirus pandemic puts this dependence in the spotlight, the Trump administration is reportedly working on making sure certain essential drugs are made at home.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.